Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 9, 2018
Patent Application Number
14086602
Date Filed
November 21, 2013
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are recombinant CMV vectors which may comprise a heterologous antigen that can repeatedly infect an organism while inducing a CD8+ T cell response to immunodominant epitopes of the heterologous antigen. The CMV vector may comprise a deleterious mutation in the US11 glycoprotein or a homolog thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
